Your session is about to expire
← Back to Search
Other
High-Protein, Low-Glycemic Diet for Metabolic Syndrome (MAPS Trial)
N/A
Waitlist Available
Research Sponsored by University of Arkansas, Fayetteville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18+ years
Be older than 18 years old
Must not have
Prescription medications related to heart disease or type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 16 weeks
Summary
This trial will test if regular potato consumption can improve cardiometabolic health in individuals with MetS.
Who is the study for?
Adults over 18 with Metabolic Syndrome, characterized by a combination of high triglycerides, low HDL cholesterol, high blood pressure, elevated fasting glucose levels or abdominal obesity. Participants should be from Northwest Arkansas and currently eating a diet high in glycemic load. Those on heart disease or diabetes medications, with needle phobia, food allergies or dietary restrictions like vegetarianism are excluded.
What is being tested?
The trial is testing the effects of a higher protein, low glycemic load diet that includes potatoes more than four times per week on individuals with Metabolic Syndrome to see if it improves their cardiometabolic health.
What are the potential side effects?
While not explicitly stated for this dietary intervention trial, potential side effects may include gastrointestinal changes such as bloating or gas due to increased fiber intake and possible changes in energy levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am taking medication for heart disease or type 2 diabetes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 16 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Plasma glucose levels
Serum lipid levels
Secondary study objectives
Appetite
Dietary intake
Marker of appetite and sleep
+4 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Higher Protein, Low Glycemic Load with PotatoesExperimental Treatment1 Intervention
Higher Protein, Low Glycemic Load with Potatoes (HPLG-P): low- to moderate- glycemic load meals containing white potatoes. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.
Group II: Higher Protein, Low Glycemic Load with Processed PotatoesActive Control1 Intervention
Higher Protein, Low Glycemic Load with Processed Potatoes (HPLG-PP): low- to moderate- glycemic load meals containing processed white potato products. Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing white potatoes.
Group III: Higher Protein, Low Glycemic Load - ControlPlacebo Group1 Intervention
Higher Protein, Low Glycemic Load (HPLG-C): low- to moderate- glycemic load meals containing control carbohydrate (e.g. rice, pasta). Participants will consume low- to moderate-glycemic meals for 16 weeks and will need to consume at least 4 meals containing control carbohydrate sources.
Find a Location
Who is running the clinical trial?
University of Arkansas, FayettevilleLead Sponsor
22 Previous Clinical Trials
1,933 Total Patients Enrolled